Skip to main content

Remote Job Finders (RJF)

FDA’s first AI-focused cGMP warning letter signals new scrutiny for manufacturers

The FDAs enforcement action against Purolea Cosmetics Lab offers an early look at how the agency expects AI-generated work to fit within existing quality systems, with experts saying human oversight and quality controls remain essential.

Braveheart, Attovia, Vogenx keep IPOs ballooning with plans to compete in cardiometabolic, immuno

Braveheart Bio is looking to take on Bristol Myers Squibb in hypertrophic cardiomyopathy, while Attovia Therapeutics wants to challenge Sanofi and Regeneron’s Dupixent. Vogenx, meanwhile, is looking to establish its name in the cardiometabolic space.
Scroll to top